• Recent news

  • Biotec – Successfully completed private placement

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.…

    Continue reading

Latest presentation

First quarter 2018 results

Loading video...

Biotec Pharmacon ASA (”Biotec”, OSE: BIOTEC) reported sales of NOK 14.2 million (18.2) in the first quarter of 2018, and a negative EBITDA of NOK 5.9 million (-4.1). Woulgan® generated sales of NOK 0.5 million during the first quarter whereas ArcticZymes generated sales of NOK 6.3 milllion. During the first quarter, results…

View more